For instance, in a study of 112 patients with bladder cancer, Minato et al. demonstrated that decreased GPX2 expression detected by immunohistochemistry in pathology specimens might be associated with cancer invasion [10]. This evidence concerns the gene GPX2 and urinary bladder carcinoma.